The largest database of trusted experimental protocols

Plvx ires neo lentivirus vector

Manufactured by Takara Bio
Sourced in China

The PLVX-IRES-Neo lentivirus vector is a lab equipment product offered by Takara Bio. It is a lentiviral vector that contains an internal ribosome entry site (IRES) and a neomycin resistance gene. The core function of this vector is to enable the expression of genes of interest in target cells.

Automatically generated - may contain errors

5 protocols using plvx ires neo lentivirus vector

1

Lentiviral Knockdown and Overexpression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NCOA4 short hairpin RNA (shRNA) was subcloned into pLVX-shRNA lentivector (Takara, Dalian, China) for NCOA4 knockdown. The sequences for NCOA4 silencing were as follow: 5’-GATCCGTCAGCAGCTCTACTCGTTATTTTCAAGAGAAATAACGAGTAGAGCTGCTGATTTTTTG-3’, and 5’-AATTCAAAAAATCAGCAGCTCTACTCGTTATTTCTCTTGAAAATAACGAGTAGAGCTGCTGACG-3’. The exogenous expression of FTH protein was performed according to our previous publication [23 (link)]. Briefly, human full-length FTH cDNA was obtained from Sino Biological (Beijing, China), and subcloned into pLVX-IRES-Neo lentivirus vector (Takara, Dalian, China) by Seamless Cloning kit (TransGen Biotech, Beijing, China). The recombinant lentiviral plasmids were verified by sequencing and co-transfected with pMD2G, pSPAX2 into 293 T cells according to the instructions of Lipofectamine 3000 (L3000008, Invitrogen) to produce recombinant lentivirus. The stable cell lines with NCOA4 silencing or FTH overexpression were obtained via lentiviral transfection and antibiotics screening. The expression level was confirmed by Western blot.
+ Open protocol
+ Expand
2

Generation of P2Y1 Receptor Knock-in Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
LLC-MK2-GCaMP6s P2Y1 knock in lines were generated by lentiviral transduction of the human P2Y1 receptor. The P2Y1 cDNA clone was purchased from GenScript (Piscataway, NJ, USA) and subcloned into pLVX-IRES-Neo lentivirus vector (Takara Bio) and packaged by the BCM Vector Development Core. LLC-MK2-GCaMP6s cells were transduced with MOI 10 in 10 µg/mL polybrene and at 72 h post-transduction selected using 500 µg/mL G418 (22 (link)). The presence of functional P2Y1 was verified by Ca2+ imaging for a Ca2+ response to 25 nM ADP.
+ Open protocol
+ Expand
3

FTH Overexpression in PANC1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full-length FTH was ordered from Sino Biological (Beijing, China) and amplified by PCR (AP131-11, TransGen Biotech), then subcloned into pLVX-IRES-Neo lentivirus vector (Takara, Dalian, China) by ClonFast Seamless Cloning kit (Obio, Nanjing, China). The recombinant lentiviral plasmid was verified by sequencing. The recombinant lentiviral plasmid was co-transfected with pMD2.G, pSPAX2 into 293T cells to produce recombinant lentiviral. After 72 h of transfection, the supernatants were collected, centrifuged, and filtered through a 0.4 μm filter. To generate stably transfected cell lines, PANC1 cells (8 × 104) were seeded in 24-well plates. After 12 h, the culture medium was removed, and cells were transfected with the corresponding lentivirus. After 2 days of transfection, 1 mg/mL G418 was added for selection for 7 days. Then the stable cells were maintained in 0.2 mg/mL G418. The transduction efficiency was evaluated by western blot analysis.
+ Open protocol
+ Expand
4

Lentiviral Knockdown and Overexpression of CISD3

Check if the same lab product or an alternative is used in the 5 most similar protocols
For knockdown of CISD3, target shRNA sequences were subcloned into pLVX-shRNA Lentivector (Takara). The shRNA knockdown sequences for CISD3 were as follows: 5′- GATCCGGCCTATCTCCACTCAAGTTCTTCAAGAGAGAACTTGAGTGGAGATAGGCCTTTTTTG-3′, and 5′- AATTCAAAAAAGGCCTATCTCCACTCAAGTTCTCTCTTGAAGAACTTGAGTGGAGATAGGCCG-3′. Full-length GPX4, FTH, Parkin, and CISD3 cDNA were ordered from Sino Biological (Beijing, China) and subcloned into pLVX-IRES-Neo lentivirus vector (Takara, Dalian, China) by ClonFast Seamless Cloning kit (obio, Nanjing, China). The shRNA-resistant form of CISD3 (CISD3res) was generated according to described methods by introducing silent changes in the coding region targeted by the shRNA [18 (link)]. All the recombinant lentiviral plasmids were verified by sequencing.
+ Open protocol
+ Expand
5

Silencing ATF4 and xCT Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression of ATF4 and xCT were silenced using pLVX-shRNA Lentivector (Takara, Japan) according to our previous publication [40 ]. The shRNA knockdown sequences are shown in Table S1 xCT cDNA was obtained from Sino Biological (Beijing, China) and subcloned into a pLVX-IRES-Neo lentivirus vector (Takara, Japan). The recombinant lentiviral plasmids were verified by sequencing and co-transfected with PMD2.G and PSPAX2 in 293T cells for lentiviral packaging. Then the supernatants were collected and filtered through a 0.45 μm filter. SMMC-7721 and Huh7 cells were plated in a 24-well plate overnight and transfected with the corresponding lentivirus for 2 days. Next, 1 mg/mL G418 or 2 μg/mL puromycin was added for the selection of stably transfected cell lines.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!